wenSymes pioneers next-generation biomanufacturing to advance global sustainability and health. Originating from the National University of Singapore, wenSymes leverages expertise in synthetic biology, precision fermentation, and green technology to produce high-value, environmentally responsible ingredients.
With a focus on scientific excellence and transformative innovation, wenSymes delivers sustainable cannabinoids, customized proteins, and scalable bioprocessing solutions for diverse industries. Committed to driving impact and fostering planetary health, wenSymes is redefining the future of biomanufacturing.
Company Details
- Employees
- 1
- Founded
- 2025
- Industry
- Biotechnology Research
- NAICS
-
Research and Development in Biotechnology (except Nanobiotechnology)
- Website
- https://wensymes.com/
- Keywords
- Singapore.
Wensymes Questions
Wensymes's website is https://wensymes.com/
Wensymes's LinkedIn profile is https://www.linkedin.com/company/wensymes
Wensymes has
1 employees.
View email and phone details for 1
employees at Wensymes.
Wensymes's industry is
Biotechnology Research
Wensymes's top competitors are
Ability Biotherapeutics,
Tjx Bioengineering,
Biomemega,
Sinergy, Singapore Consortium For Synthetic Biology,
Nsg Biolabs,
Wasion Energy,
Peptobiotics,
Biopeak Health,
Seedlab,
Corporateconnections® Singapore.
Wensymes's categories are Biotechnology Research
Wensymes's founding year is 2025
